menu
    • menu

    Company profile for Eureka Therapeutics

    NEW Drugs in Dev: 6
    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

    Virtual Booth

    Contact Supplier

    Cosma S.p.A., part of CFM Group with AMSA & Clarochem, provides global pharma & veterinary health with 300+ tons of FDA-approved APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are a clinical stage biopharmaceutical company with the goal of curing cancer by developing novel T-cell therapies that harness the evolutionary power of the immune system. We believe T-cell therapy represents a revolutionary step toward providing a potential cure for many forms of cancer, including cancers poorly addressed by current approaches. At Eureka, our mission is to make safe and effective T-cell therapies that are...
    We are a clinical stage biopharmaceutical company with the goal of curing cancer by developing novel T-cell therapies that harness the evolutionary power of the immune system. We believe T-cell therapy represents a revolutionary step toward providing a potential cure for many forms of cancer, including cancers poorly addressed by current approaches. At Eureka, our mission is to make safe and effective T-cell therapies that are widely accessible to patients as the standard of care for the treatment of multiple hematologic and solid tumors.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Eureka TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    5858 Horton St, Suite 170 Emeryville, CA 94608
    Telephone
    Telephone
    (510) 654-7045
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.eurekatherapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/eureka-therapeutics-inc/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/eurekathera

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    SCOPE Summit

    SCOPE Summit

    Not Confirmed

    envelop Contact Supplier

    SCOPE Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    FDA Grants RMAT To ECT204, ARTEMIS CAR T-Cell Therapy
    FDA Grants RMAT To ECT204, ARTEMIS CAR T-Cell Therapy

    12 Jan 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-01-12/us-fda-grants-rmat-designation-to-ect204-an-artemis-car-abtcr-t-cell-therapy-for-advanced-hepa

    PHARMIWEB
    12 Jan 2026
    Share Share
    Eureka's ARTEMIS CAR-T Breakthrough in Solid Tumors: NCI Study
    Eureka's ARTEMIS CAR-T Breakthrough in Solid Tumors: NCI Study

    13 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251113553305/en/Eurekas-ARTEMIS-CAR-T-Cells-Show-Breakthrough-Potential-in-Solid-Tumors-in-NCI-Led-Study-Published-in-Cell-Reports-Medicine

    BUSINESSWIRE
    13 Nov 2025
    Share Share
    Eureka Therapeutics Adds Dr. Seeto and W. Solari III to Board
    Eureka Therapeutics Adds Dr. Seeto and W. Solari III to Board

    12 Aug 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250812687577/en/Eureka-Therapeutics-Appoints-Dr.-Reginald-Seeto-and-William-S.-Solari-III-to-Board-of-Directors

    BUSINESSWIRE
    12 Aug 2025
    Share Share
    Eureka Therapeutics Appoints Liver Cancer Expert Dr. Samuel So
    Eureka Therapeutics Appoints Liver Cancer Expert Dr. Samuel So

    05 Aug 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250805792746/en/Eureka-Therapeutics-Adds-Stanford-Liver-Cancer-Expert-Dr.-Samuel-So-to-Scientific-Advisory-Board

    BUSINESSWIRE
    05 Aug 2025
    Share Share
    GBA Group' Eureka acquires majority stake in Teena Biolabs
    GBA Group' Eureka acquires majority stake in Teena Biolabs

    03 Apr 2025

    // EXPRESSPHARMA

    https://www.expresspharma.in/gba-groups-eureka-acquires-majority-stake-in-teena-biolabs/

    EXPRESSPHARMA
    03 Apr 2025
    Share Share
    Porton Advanced partners with Eureka Therapeutics for TCell Therapy
    Porton Advanced partners with Eureka Therapeutics for TCell Therapy

    19 Mar 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/porton-advanced-announces-collaboration-with-eureka-therapeutics-to-accelerate-tcell-therapy-development-302405703.html

    PR NEWSWIRE
    19 Mar 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search